S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
NYSE:SYK

Stryker Stock Forecast, Price & News

$254.68
-2.34 (-0.91%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$252.44
$258.42
50-Day Range
$236.63
$277.77
52-Week Range
$220.90
$281.16
Volume
2.59 million shs
Average Volume
1.48 million shs
Market Capitalization
$96.04 billion
P/E Ratio
51.24
Dividend Yield
1.08%
Beta
1
30 days | 90 days | 365 days | Advanced Chart
Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.


Stryker logo

About Stryker

Stryker Corp. engages in the provision of medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg, and Neurotechnology & Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The MedSurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling and reprocessed medical devices. The Neurotechnology & Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
86366710
Employees
43,000
Year Founded
1941

Sales & Book Value

Annual Sales
$14.35 billion
Cash Flow
$9.25 per share
Book Value
$34.82 per share

Profitability

Net Income
$1.60 billion
Pretax Margin
13.17%

Debt

Price-To-Earnings

Miscellaneous

Free Float
351,831,000
Market Cap
$96.04 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 10/29 Dividend
9/29/2021
Last Earnings
10/27/2021
Dividend Payable
10/29/2021
Ex-Dividend for 1/31 Dividend
12/30/2021
Today
1/23/2022
Next Earnings (Confirmed)
1/27/2022
Dividend Payable
1/31/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

3.15 out of 5 stars

Medical Sector

15th out of 1,418 stocks

Surgical & Medical Instruments Industry

2nd out of 130 stocks

Analyst Opinion: 3.3Community Rank: 4.5Dividend Strength: 4.2Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












Stryker (NYSE:SYK) Frequently Asked Questions

Is Stryker a buy right now?

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Stryker stock.
View analyst ratings for Stryker
or view top-rated stocks.

How has Stryker's stock been impacted by COVID-19?

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SYK shares have increased by 45.0% and is now trading at $254.68.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Stryker?

Stryker saw a increase in short interest in December. As of December 31st, there was short interest totaling 4,800,000 shares, an increase of 19.4% from the December 15th total of 4,020,000 shares. Based on an average trading volume of 1,260,000 shares, the days-to-cover ratio is presently 3.8 days. Approximately 1.4% of the shares of the stock are short sold.
View Stryker's Short Interest
.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Thursday, January 27th 2022.
View our earnings forecast for Stryker
.

How can I listen to Stryker's earnings call?

Stryker will be holding an earnings conference call on Thursday, January 27th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 929-458-6194 with passcode "064681".

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) released its quarterly earnings data on Wednesday, October, 27th. The medical technology company reported $2.20 EPS for the quarter, missing the Zacks' consensus estimate of $2.28 by $0.08. The medical technology company had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.23 billion. Stryker had a net margin of 11.40% and a trailing twelve-month return on equity of 25.73%. The company's revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter last year, the company posted $2.14 earnings per share.
View Stryker's earnings history
.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Thursday, December 9th. Investors of record on Friday, December 31st will be given a dividend of $0.695 per share on Monday, January 31st. This represents a $2.78 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date is Thursday, December 30th. This is a boost from Stryker's previous quarterly dividend of $0.63.
View Stryker's dividend history
.

Is Stryker a good dividend stock?

Stryker pays an annual dividend of $2.78 per share and currently has a dividend yield of 1.08%. Stryker has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Stryker is 55.94%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Stryker will have a dividend payout ratio of 27.42% next year. This indicates that Stryker will be able to sustain or increase its dividend.
View Stryker's dividend history.

What guidance has Stryker issued on next quarter's earnings?

Stryker issued an update on its FY 2021 earnings guidance on Thursday, November, 4th. The company provided earnings per share (EPS) guidance of $9.080-$9.150 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.300. The company issued revenue guidance of -.

What price target have analysts set for SYK?

20 brokers have issued 1 year target prices for Stryker's stock. Their forecasts range from $265.00 to $320.00. On average, they expect Stryker's share price to reach $294.84 in the next year. This suggests a possible upside of 15.8% from the stock's current price.
View analysts' price targets for Stryker
or view top-rated stocks among Wall Street analysts.

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Kevin A. Lobo, Chairman, President & Chief Executive Officer (LinkedIn Profile)
  • Timothy J. Scannell, Executive Advisor
  • Glenn S. Boehnlein, Chief Financial Officer & Vice President
  • Alan Douville, Chief Information Officer & Vice President
  • Dana S. McMahon, Chief Compliance Officer & Vice President

What is Kevin A. Lobo's approval rating as Stryker's CEO?

1,492 employees have rated Stryker CEO Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among Stryker's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a variety of retail and institutional investors. Top institutional investors include Nordea Investment Management AB (0.34%), Royal London Asset Management Ltd. (0.20%), Fenimore Asset Management Inc. (0.15%), Welch & Forbes LLC (0.14%), Boston Trust Walden Corp (0.11%) and LGT Capital Partners LTD. (0.10%). Company insiders that own Stryker stock include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Roch Doliveux, Ronda E Stryker, Srikant M Datar and Timothy J Scannell.
View institutional ownership trends for Stryker
.

Which institutional investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Confluence Investment Management LLC, Royal London Asset Management Ltd., M&G Investment Management Ltd., Ferguson Wellman Capital Management Inc., Parallel Advisors LLC, State of Alaska Department of Revenue, and IBM Retirement Fund. Company insiders that have sold Stryker company stock in the last year include Glenn S Boehnlein, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Ronda E Stryker, and Srikant M Datar.
View insider buying and selling activity for Stryker
or view top insider-selling stocks.

Which institutional investors are buying Stryker stock?

SYK stock was acquired by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Stonnington Group LLC, Ardent Capital Management Inc., Tandem Investment Advisors Inc., Bedrijfstakpensioenfonds Voor DE Media PNO, LGT Capital Partners LTD., Charles Carroll Financial Partners LLC, and Carnegie Capital Asset Management LLC.
View insider buying and selling activity for Stryker
or or view top insider-buying stocks.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $254.68.

How much money does Stryker make?

Stryker has a market capitalization of $96.04 billion and generates $14.35 billion in revenue each year. The medical technology company earns $1.60 billion in net income (profit) each year or $4.97 on an earnings per share basis.

How many employees does Stryker have?

Stryker employs 43,000 workers across the globe.

Does Stryker have any subsidiaries?

The following companies are subsidiares of Stryker: ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc, Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, CHG Hospital Beds, Cactus LLC, Cardan Robotics, Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, Concentric Medical Inc., Entellus Medical, Entellus Medical Europe Ltd, Entellus Medical Inc., GYS Tech LLC, Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Technology Inc., ITAPCo Limited, Image Guided Technologies, Imorphics Limited, Infinity MSD Corp., Infinity MSE Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Germany GmbH, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Iberia Medcomtech S.L.U., K2M Inc., K2M Solutions Australia Pty Ltd, K2M Spine Solutions (Schweiz) GmbH, K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Hong Kong Ltd, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, OrthoSpace, OrthoSpace Ltd., OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, Patient Safety Technologies, Patton Surgical, Pficonprod Pty. Ltd., Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Czech Sales s.r.o., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Hungary Sales Kft, Physio-Control Inc., Physio-Control India Sales Pvt. Ltd, Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Physio-Control Singapore Pte. Ltd., Physio-Control South Africa Sales Pty. Ltd., Physio-Control UK Sales Ltd., Pivot Medical, PlasmaSol, Porex Technologies, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions BV, Stryker Asia Holdings CV, Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold BV, Stryker Beteiligungs GmbH, Stryker Canada GP ULC, Stryker Canada Holding Company, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Canadian Sales Holding Company ULC, Stryker Capital BV, Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services BV, Stryker Employment Company LLC, Stryker European Coordination Center BV, Stryker European Holdings Coöperatief U.A, Stryker European Holdings I LLC, Stryker European Holdings II LLC, Stryker European Holdings LLC, Stryker European Holdings V LLC, Stryker European Operations B.V., Stryker European Operations Holdings I BV, Stryker European Operations Holdings II BV, Stryker European Operations Holdings III BV, Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker European Technologies C.V., Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France Holding SNC, Stryker France MM Holdings SAS, Stryker France SAS, Stryker Funding B.V., Stryker GI Services CV, Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings BV, Stryker IFSC Designated Activity Company, Stryker Iberia SL Unipersonal, Stryker India Private Limited, Stryker International Acquisitions BV, Stryker International Holdings BV, Stryker Investment Holdings B.V., Stryker Ireland Holding Unlimited Company, Stryker Ireland Limited, Stryker Italia S.r.l. S.U., Stryker Japan Holdings BV, Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Holdings S.a.r.l., Stryker Luxembourg Sarl, Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland BV, Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Limited, Stryker Romania SRL, Stryker Sage Inc., Stryker Sales Corporation, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Trauma GmbH, Stryker Turkish Holdings BV, Stryker UK Ltd, Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TG SP Holdings Corp, TSO3 Corp, TSO3 Inc, Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (BVI) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, VEXIM SA, Vexim, Waterloo Bedding Co., Wright Medical Group, ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.

When was Stryker founded?

Stryker was founded in 1941.

What is Stryker's official website?

The official website for Stryker is www.strykercorp.com.

Where are Stryker's headquarters?

Stryker is headquartered at 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at (269) 385-2600, via email at [email protected], or via fax at 269-385-1062.


This page was last updated on 1/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.